Hepatoprotective activity of exogenous RNA

Thioacetamide Parenchyma Thiol
DOI: 10.15407/ubj87.04.037 Publication Date: 2015-07-28T06:08:52Z
ABSTRACT
Hepatoprotective activity of Nuclex, a pharmaceutical composed low-molecular yeast RNA, was investigated during acute and chronic thioacetamide-induced hepatotoxicity. It is demonstrated, that Nuclex administration at dose 200 mg/kg liver injury produces hepatoprotective effect, which associated with decrease in parenchyma lesions its inflammatory infiltration. application attenuates free radical damage hepatic biopolymers, expressed the reduction TBA-reactive products, carbonyl derivatives, recovery protein thiol groups reduced glutathione levels.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....